Rincon lithium project: US$2.5bn cost, 60,000tpa capacity, DLE technology and 2028 production timeline
Read More Pharma Industry News Mereo BioPharma completes patient enrollment for BPS-804 Phase 2b trial in osteogenesis imperfecta British specialty biopharma company Mereo BioPharma Group has completed patient enrollment for a Phase 2b clinical trial of… bypharmanewsdailyOctober 30, 2018